Instruction for use: Betliben

ATX Code D07AC01 Beclometasone

Active substance: Betamethasone

Pharmacological group

Glucocorticosteroid for topical use [Glucocorticosteroids]

Nosological classification (ICD-10)

L20 Atopic dermatitis

Itchy atopic eczema, Common neurodermatitis, Allergic skin diseases, Allergic skin diseases of non-infectious etiology, Allergic skin diseases of non-microbial etiology, Allergic skin diseases, Allergic skin lesions, Allergic manifestations on the skin, Allergic dermatitis, Allergic diathesis, Allergic itching dermatosis, Allergic Skin Disease, Allergic skin irritation, Dermatitis allergic, Atopic dermatitis, Dermatosis allergic, Diathesis exudative, Skin Allergic Disease, Skin allergic reaction to medicinal and chemical preparations, Skin reaction to medication, Skin and allergic disease, Acute eczema, Chronic atopic dermatitis, Exudative diathesis, Itching allergic dermatosis

L20.8 Other atopic dermatitis

Constitutional neurodermatitis, Chronic neurodermatitis, Restricted neurodermatitis, Allergic eczema, Atopic eczema, Children's eczema, Diffuse neurodermatitis, Neurodermatitis, Neurodermatitis diffuse, Neurodermatitis limited, Neurodermatitis, Dermatosis of a neurogenic origin

L21 Seborrheic dermatitis

Dermatitis seborrheic, Increased sebum separation, Seborrheic Eczema, Seborrheic dermatitis of the scalp, Seborrheic pyodermatitis, Seborrhea, Eczema seborrheic

L23 Allergic contact dermatitis

Allergic dermatitis, Purulent allergic dermatopathies, Contact allergic reaction, Contact allergic dermatitis, Photoallergic contact dermatitis

L25 Contact dermatitis, unspecified

Intertriginous dermatitis, Contact Eczema, Contact dermatitis, Contact dermatitis of non-microbial etiology, Contact dermatitis, Skin wetting surface, Fractures, Intertrigo,Skin Difficulty, Subacute and chronic contact dermatitis, Phlebotoderma, Simple contact dermatitis complicated by impetigo

L29 Itching

Itching with partial obstruction of the biliary tract, Dermatitis itchy, Dermatosis with persistent itching, Other itching dermatoses, Itching dermatoses, Itching allergic dermatosis, Itching dermatitis, Itching itch, Excruciating itching, Severe itching, Endogenous itching, Skin itching with dermatosis, Limited itching dermatitis, Itching of the skin, Itchy scalp, Itching eczema

L30.1 Dyshidrosis [pomfolix]

Skin dyshidrosis, Pomfolix, Eczema dysgidrotic, Dyshidrotic eczema, Infected dyshidrosis, Dyshidrosis, Dyshidrotic dermatitis

L30.9 Dermatitis, unspecified

Allergic dermatoses complicated by a secondary bacterial infection, Anal eczema, Bacterial maturation, Varicose Eczema, Venous dermatitis, Inflammation of the skin, Inflammation of the skin upon contact with plants, Inflammatory Skin Diseases, Inflammatory skin reactions, Inflammatory processes of the skin, Hypostatic dermatitis, Fungal Eczema, Fungal dermatosis, Dermatitis, Dermatitis is stagnant, Dermatitis and eczema in the anal area, Dermatitis acute contact, Perianal dermatitis, Dermatosis, Dermatosis of the scalp, Dermatosis of psoriasis, Dermatosis with persistent itching, Dermatoses, Dermatoses itchy, Other itching dermatoses, Significant eczematous manifestations, Itching with, dermatoses, Itching eczema, True eczema, Skin reaction to insect bites,Skin itching with dermatosis, Constitutional eczema, Weeping eczema, Drowsing inflammatory skin disease, Dying Infectious-Inflammatory Skin Disease, Non-allergic dermatitis, Nummular eczema, Acute contact eczema, Acute inflammatory skin disease, Acute dermatosis, Acute severe dermatosis, Perianal dermatitis, Superficial dermatosis, Subacute Contact Eczema, Simple dermatitis, Occupational dermatitis, Psychogenic dermatosis, Bubble dermatitis of newborns, Pustular eruptions, Irritation and redness of the skin, Low-flammable eczema, Dry atrophic eczema, Dry eczema, Toxic dermatitis, Ear eczema like dermatitis, Chronic eczema, Chronic dermatosis, Chronic common dermatosis, Scaly papular dermatosis, Eczema, Eczema anal region, Eczema of the hands, Eczema Contact, Eczema lichenized, Eczema Nummular, Eczema acute, Eczema acute contact, Eczema subacute, Eczematous dermatitis, Eczema-like rashes, Ecome exogenous, Endogenous eczema, Gluteal dermatitis, Restricted itchy dermatitis

L40 Psoriasis

Chronic psoriasis with diffuse plaques, Generalized psoriasis, Psoriasis of the scalp, Psoriasis of the scalp, Generalized form of psoriasis, Psoriasis dermatitis, Psoriasis complicated by erythroderma, Invalidative psoriasis, Isolated psoriatic plaque, Exfoliative psoriasis, Psoriatic Erythroderma, Psoriasis with eczematosis, Hyperkeratosis in psoriasis,Inverse psoriasis,Psoriasis eczematous, Dermatosis of psoriasis, Psoriasis of the genitals, Psoriasis with lesions of hairy areas of skin, Erythrodermal psoriasis, Chronic psoriasis of the scalp, Chronic psoriasis, Ordinary psoriasis, Refractory psoriasis, Kebner phenomenon, Scaly lichen

L56.3 Solar Urticaria

Skin irritation after sun exposure, Sun Dermatitis, Dermatitis sunflower

L56 Other acute skin changes caused by ultraviolet radiation

Impact of UV rays, Acute skin changes caused by ultraviolet radiation, Sun Dermatitis, Photodermatitis, Photodermatosis, Dermatitis sunflower

Composition

Cream for external use 100 g

active substance:

Betamethasone dipropionate 0.0643 g

(Equivalent to 0.05 g of betamethasone)

Auxiliary substances: paraffin white soft - 16,7 g; Paraffin liquid - 6.7 g; Cremophor A25 (macrogol ester of cetostearyl A25) - 2.5 g; Cremophor A6 (macrogol ester of cetostearyl A6) - 2.5 g; Cetostearyl alcohol (cetyl alcohol - 60%, stearyl alcohol - 40%) - 5.5 g; Propylene glycol 5.5 g; Methyl parahydroxybenzoate 0.07 g; Propyl parahydroxybenzoate 0.03 g; Disodium edetate 0.1 g; Sodium dihydrogen phosphate dihydrate 0.21 g; Sodium hydrophosphate dihydrate - 0.0151 g; Purified water - 60.1106 g

Ointment for external use 100 g

active substance:

Betamethasone dipropionate 0.0643 g

(Equivalent to 0.05 g of betamethasone)

Auxiliary substances: paraffin white soft - 94,9357 g; Paraffin liquid - 5 g

pharmachologic effect

Pharmacological action - anti-inflammatory, anti-edematous, antiallergic, antipruritic, antiexudative.

Dosing and Administration

Outwardly. Apply to the affected area of the skin with a thin layer 1 or 2 times a day, lightly rubbing. On sites with more dense skin (for example elbows, palms and feet), and also places from which the preparation is easily erased, it can be applied more often. The duration of continuous treatment is usually not more than 4 weeks.

To prevent relapse in the treatment of chronic diseases, therapy should continue for some time after the disappearance of all symptoms. During the year, repeated courses of therapy are possible.

In children and patients with skin lesions, treatment should not exceed 5 days.

In addition to the cream for external use

Cream for external use is used for acute therapy, incl. Wetting skin lesions.

Additionally for ointments for external use

Ointment for external use is intended for the therapy of subacute and chronic dermatoses, incl. Dry, lichenic and flaky lesions, or in cases where the use of ointment for occlusive dressing is necessary.

Form of issue

Cream for external use, 0.05%. In an aluminum tube, coated twice with a protective varnish, with a sealed hole, a protective membrane and a plastic cap provided with a cone-shaped device for puncturing the protective membrane, 25 g. 1 tube in a cardboard bundle.

Ointment for external use, 0.05%. In an aluminum tube, coated twice with a protective varnish, with a sealed hole, a protective membrane and a plastic cap provided with a cone-shaped device for puncturing the protective membrane, 25 g. 1 tube in a cardboard bundle.

Terms of leave from pharmacies

Without recipe.

Storage conditions

At a temperature not exceeding 25 ° C.

Keep out of the reach of children.

Shelf life

2 years.

Do not use after the expiry date printed on the package.